Category: Biomanufacturing@MIT-CBI
-
FDA funds Center for Continuous mRNA Manufacturing
Researchers from MIT have received an award of $82 million over 3 years from the Food & Drug Administration (FDA) Center for Biologics Evaluation &…
-
CAACB Publishes on NGS
The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) collected historical data from 20 biopharmaceutical industry members on their experience with the in vivo adventitious…
-
SMART researchers enable early-stage detection of microbial contamination in cell therapy
Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have identified a critical quality attribute that potentially allows the development…
-
Applying Nanofluidics to Enhance Biomanufacturing
AZoNano interviews Biomanfacturing@MIT-CBI collaborator Dr. Georgios ‘Yorgos’ Katsikis, a researcher in the laboratory of Scott Manalis, the Andrew (1956) and Erna Viterbi Professor, Professor of…
-
ONLINE COURSE ABOUT CELL THERAPIES ENROLLING NOW!
This nine-week self-paced course launches March 9th, 2022. Learn more and enroll HERE!
-
Biomanufacturing@MIT-CBI Research Published in ‘Biomaterials’.
Biomanufacturing@MIT-CBI researchers provide an in-depth analysis of bioprocess technologies needed for cell-based meat production and challenges in reaching commercial scale. Specifically, it reviews state-of-the-art bioprocess technologies,…
-
The world needs more vaccines faster. A tiny tube could make all the difference.
Professor Richard Braatz was interviewed for an article in National Geographic about efforts to develop a continuous manufacturing processes that could help boost global vaccine…
-
Enroll in MIT xPro Course through March 3rd!
Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and…
-
BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.
BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody treatments affordable and available, particularly…
-
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the…